CLINICAL_TRIALS
trial_result
· 2023-12-27
Clinical Trial Update: Phase II Study of TAEST16001 in Soft Tissue Sarcoma [Phase 2]
Summary
Phase II trial update is provided for TAEST16001 in soft tissue sarcoma, with the study status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN